Oric Pharmaceuticals Ratios (2019-2026) | ORIC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Efficiency
Assets Average (Quarter)										276.09M	291.20M	306.41M	286.85M	267.37M	248.84M	242.59M	236.91M	259.23M	283.08M	263.17M	301.40M	339.85M	315.49M	288.11M	258.50M	294.86M	389.02M	420.04M	422.83M
Equity Average (Quarter)										267.20M	274.93M	282.26M	263.03M	244.97M	225.84M	218.59M	212.58M	235.81M	258.11M	235.75M	276.37M	315.52M	288.20M	258.56M	231.43M	271.87M	365.46M	395.64M	399.96M
Invested Capital (Quarter)										258.32M	291.54M	272.98M	253.08M	236.87M	214.82M	222.35M	202.81M	268.80M	247.41M	224.09M	328.64M	302.40M	273.99M	243.12M	219.74M	324.00M	406.92M	384.36M	415.56M
Leverage & Solvency
Equity Ratio (Quarter)										0.96	0.93	0.91	0.92	0.91	0.90	0.90	0.89	0.92	0.90	0.89	0.94	0.92	0.91	0.89	0.90	0.93	0.94	0.94	0.95
Valuation
Enterprise Value (Quarter)										-261.07M	-289.52M	-236.98M	-234.62M	-227.06M	-193.66M	-206.27M	-189.63M	-264.16M	-227.30M	-208.19M	-316.78M	-286.41M	-272.37M	-255.96M	-203.72M	-282.51M	-287.14M	-281.49M	-281.93M
Return Ratios
Return on Capital Employed (Quarter)										-34.37%	-30.20%	-27.08%	-31.11%	-33.43%	-39.25%	-40.39%	-42.42%	-40.25%	-38.42%	-45.64%	-39.87%	-39.06%	-45.80%	-54.28%	-60.87%	-54.07%	-40.13%	-35.78%	-37.01%
Return on Assets (Quarter)										0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	0.00%	0.00%	0.00%
Return on Equity (Quarter)										0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%